Published: 5 July 2021
Author(s): Elsa Dent, Jean Woo, David Scott, Emiel O. Hoogendijk
Issue: August 2021
Section: Review Article

Sarcopenia is defined as an accelerated loss of skeletal muscle mass associated with decreased functional capacity [1–3]. The disease can range in severity from very mild to severe, preventing an individual performing activities of daily living (ADLs) and increasing the risk of functional decline, mortality, frailty, and incidence of hospitalisation [4–17]. Most cases of sarcopenia are attributed to physical inactivity and inadequate protein/energy intake [18–22], although a myriad of other factors can also contribute, including: chronic disease [2,23], polypharmacy [2,23], hyperlipidaemia [23], and the ‘anorexia of ageing’ (age-attributed weight loss) [24,25].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.